跳至主要内容
临床试验/CTRI/2022/09/045736
CTRI/2022/09/045736尚未招募4 期

To compare the efficacy of two combination therapies against carbapenem resistant enterobacteriaceaeMeropenem plus colistin versus high dose tigecycline plus colistin in critically ill patients.

Department of Anaesthesiology and Critical and Care Jawaharlal Nehru Medical College AMU Aligarh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patient having sepsis and SOFA score of 2 or more than 2 at the time of admission in icu/ccw.
  • 2.There should be an isolates of carbapenem resistant enterobacteriaceae (CRE) positive either from Blood, tracheal aspirates, urine or abdominal pus culture.
  • 3.Patient on any empirical antibiotics except current combination therapy .

排除标准

  • 1.Patient who is not having sepsis and having SOFA score of less than 2. Non Carbapenem resistant enterobacteriaceae (CRE) patients.
  • 3.Patient who expire within 48 hours of starting the combination
  • 4.Patient having sensitivity to the drug use .
  • 5.Covid -19 positive patients

研究者

发起方
Department of Anaesthesiology and Critical and Care Jawaharlal Nehru Medical College AMU Aligarh

相似试验